Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Microbial Sensitivity Tests | 33 | 2024 | 1937 | 4.910 |
Why?
|
Anti-Bacterial Agents | 35 | 2024 | 7407 | 4.250 |
Why?
|
Enterobacteriaceae | 8 | 2018 | 161 | 3.250 |
Why?
|
Nebramycin | 5 | 2019 | 10 | 3.020 |
Why?
|
Drug Resistance, Multiple, Bacterial | 13 | 2022 | 587 | 2.050 |
Why?
|
Legionella pneumophila | 7 | 2017 | 49 | 1.910 |
Why?
|
Brucella | 3 | 2019 | 10 | 1.890 |
Why?
|
Anti-Infective Agents | 4 | 2024 | 983 | 1.610 |
Why?
|
Colistin | 4 | 2022 | 44 | 1.610 |
Why?
|
High-Throughput Screening Assays | 5 | 2020 | 934 | 1.590 |
Why?
|
Klebsiella pneumoniae | 6 | 2023 | 250 | 1.570 |
Why?
|
Candida | 3 | 2021 | 172 | 1.520 |
Why?
|
Enterobacteriaceae Infections | 5 | 2020 | 188 | 1.450 |
Why?
|
Neisseria gonorrhoeae | 4 | 2024 | 239 | 1.410 |
Why?
|
Bacteriological Techniques | 5 | 2013 | 275 | 1.370 |
Why?
|
Acinetobacter baumannii | 4 | 2020 | 118 | 1.360 |
Why?
|
Automation, Laboratory | 3 | 2020 | 102 | 1.330 |
Why?
|
Drug Synergism | 8 | 2022 | 1756 | 1.220 |
Why?
|
Bacteria | 5 | 2022 | 2199 | 1.210 |
Why?
|
Microbiological Techniques | 2 | 2019 | 97 | 1.150 |
Why?
|
Bacteremia | 4 | 2024 | 980 | 1.130 |
Why?
|
Molecular Diagnostic Techniques | 3 | 2021 | 610 | 1.120 |
Why?
|
beta-Lactamases | 7 | 2023 | 304 | 1.100 |
Why?
|
Bacterial Infections | 5 | 2019 | 1391 | 1.010 |
Why?
|
Carbapenems | 4 | 2023 | 123 | 1.000 |
Why?
|
Specimen Handling | 5 | 2024 | 702 | 0.970 |
Why?
|
Blood | 5 | 2017 | 596 | 0.930 |
Why?
|
Gonorrhea | 4 | 2024 | 346 | 0.900 |
Why?
|
Streptothricins | 1 | 2023 | 5 | 0.890 |
Why?
|
Freezing | 1 | 2024 | 311 | 0.860 |
Why?
|
Drug Resistance, Bacterial | 4 | 2019 | 1048 | 0.810 |
Why?
|
Phagosomes | 3 | 2019 | 199 | 0.800 |
Why?
|
Zoonoses | 2 | 2024 | 179 | 0.800 |
Why?
|
Microscopy | 5 | 2018 | 903 | 0.780 |
Why?
|
Pseudomonas aeruginosa | 3 | 2018 | 1277 | 0.750 |
Why?
|
Staphylococcus aureus | 3 | 2018 | 1457 | 0.750 |
Why?
|
Reagent Kits, Diagnostic | 2 | 2014 | 239 | 0.740 |
Why?
|
Clinical Laboratory Techniques | 4 | 2022 | 746 | 0.740 |
Why?
|
Laboratory Chemicals | 1 | 2020 | 2 | 0.730 |
Why?
|
Chlamydia trachomatis | 2 | 2014 | 239 | 0.730 |
Why?
|
Steam | 1 | 2020 | 33 | 0.720 |
Why?
|
Staphylococcal Infections | 3 | 2018 | 1407 | 0.710 |
Why?
|
Decontamination | 1 | 2020 | 73 | 0.690 |
Why?
|
Quality Control | 2 | 2020 | 832 | 0.690 |
Why?
|
Spectinomycin | 1 | 2019 | 9 | 0.670 |
Why?
|
Communicable Diseases | 2 | 2020 | 875 | 0.660 |
Why?
|
beta-Lactam Resistance | 2 | 2017 | 73 | 0.660 |
Why?
|
Streptococcal Infections | 1 | 2024 | 617 | 0.650 |
Why?
|
Fever | 2 | 2017 | 1618 | 0.650 |
Why?
|
Computer Peripherals | 1 | 2019 | 38 | 0.640 |
Why?
|
Brucellosis | 1 | 2018 | 21 | 0.640 |
Why?
|
Chlamydia Infections | 2 | 2014 | 365 | 0.640 |
Why?
|
Lung Diseases, Fungal | 2 | 2017 | 126 | 0.640 |
Why?
|
Headache | 2 | 2017 | 1256 | 0.630 |
Why?
|
Ceftazidime | 1 | 2018 | 57 | 0.620 |
Why?
|
Malaria, Falciparum | 2 | 2017 | 1077 | 0.620 |
Why?
|
Gentian Violet | 1 | 2018 | 26 | 0.610 |
Why?
|
Azabicyclo Compounds | 1 | 2018 | 68 | 0.610 |
Why?
|
Phenazines | 1 | 2018 | 56 | 0.600 |
Why?
|
Masks | 1 | 2020 | 208 | 0.590 |
Why?
|
Amikacin | 1 | 2017 | 47 | 0.570 |
Why?
|
Technology, Pharmaceutical | 1 | 2017 | 84 | 0.570 |
Why?
|
Membrane Transport Proteins | 1 | 2023 | 1035 | 0.570 |
Why?
|
Bacterial Vaccines | 1 | 2019 | 401 | 0.560 |
Why?
|
Bartonella | 2 | 2010 | 11 | 0.560 |
Why?
|
Tobramycin | 1 | 2017 | 65 | 0.560 |
Why?
|
Macrophages | 5 | 2019 | 5769 | 0.560 |
Why?
|
Thigh | 1 | 2018 | 241 | 0.550 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2021 | 366 | 0.550 |
Why?
|
Eukaryotic Cells | 2 | 2016 | 195 | 0.550 |
Why?
|
Blastomyces | 1 | 2016 | 10 | 0.540 |
Why?
|
Escherichia coli | 5 | 2023 | 4217 | 0.540 |
Why?
|
Blastomycosis | 1 | 2016 | 14 | 0.540 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 687 | 0.530 |
Why?
|
Gentamicins | 1 | 2017 | 243 | 0.520 |
Why?
|
Candidiasis | 2 | 2017 | 365 | 0.520 |
Why?
|
Fever of Unknown Origin | 1 | 2016 | 94 | 0.510 |
Why?
|
Cephalosporins | 1 | 2016 | 198 | 0.510 |
Why?
|
Equipment Contamination | 1 | 2017 | 182 | 0.500 |
Why?
|
Influenza, Human | 2 | 2021 | 1521 | 0.500 |
Why?
|
Limit of Detection | 5 | 2022 | 273 | 0.490 |
Why?
|
Mediastinal Diseases | 1 | 2015 | 91 | 0.490 |
Why?
|
Public Policy | 1 | 2019 | 559 | 0.490 |
Why?
|
Sensitivity and Specificity | 12 | 2022 | 14666 | 0.480 |
Why?
|
Cryptococcus | 1 | 2014 | 28 | 0.480 |
Why?
|
Small Molecule Libraries | 2 | 2019 | 733 | 0.470 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3086 | 0.460 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 1334 | 0.460 |
Why?
|
Cryptococcosis | 1 | 2014 | 104 | 0.450 |
Why?
|
Aminoglycosides | 3 | 2020 | 160 | 0.450 |
Why?
|
Lymphatic Diseases | 1 | 2015 | 320 | 0.450 |
Why?
|
DNA Replication | 1 | 2020 | 1418 | 0.440 |
Why?
|
Rib Fractures | 1 | 2014 | 128 | 0.430 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1089 | 0.420 |
Why?
|
Cough | 1 | 2016 | 594 | 0.400 |
Why?
|
Cytoplasm | 1 | 2016 | 1510 | 0.390 |
Why?
|
Bacterial Proteins | 8 | 2023 | 3847 | 0.390 |
Why?
|
Nasopharynx | 4 | 2022 | 401 | 0.380 |
Why?
|
Gram-Negative Bacteria | 2 | 2023 | 272 | 0.380 |
Why?
|
Autophagy | 1 | 2019 | 1326 | 0.380 |
Why?
|
Disease Outbreaks | 2 | 2017 | 1749 | 0.360 |
Why?
|
Bartonella Infections | 1 | 2010 | 21 | 0.360 |
Why?
|
Humans | 74 | 2024 | 761572 | 0.350 |
Why?
|
Klebsiella Infections | 2 | 2023 | 146 | 0.340 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2009 | 66 | 0.340 |
Why?
|
Fluorescent Dyes | 2 | 2015 | 1903 | 0.330 |
Why?
|
Fusidic Acid | 2 | 2019 | 15 | 0.330 |
Why?
|
Disease Models, Animal | 3 | 2018 | 18253 | 0.320 |
Why?
|
Population Surveillance | 1 | 2019 | 2598 | 0.310 |
Why?
|
Immunocompromised Host | 3 | 2016 | 857 | 0.310 |
Why?
|
Minocycline | 3 | 2022 | 169 | 0.310 |
Why?
|
Acinetobacter Infections | 2 | 2020 | 73 | 0.310 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3206 | 0.310 |
Why?
|
Polymerase Chain Reaction | 5 | 2022 | 6075 | 0.300 |
Why?
|
Antigens, Viral | 2 | 2024 | 988 | 0.290 |
Why?
|
Coagulase | 1 | 2007 | 54 | 0.290 |
Why?
|
Mycobacterium | 1 | 2009 | 251 | 0.280 |
Why?
|
Public Health | 2 | 2022 | 2669 | 0.280 |
Why?
|
Pneumocystis carinii | 1 | 2007 | 72 | 0.280 |
Why?
|
Bacterial Toxins | 3 | 2018 | 932 | 0.280 |
Why?
|
HIV Seronegativity | 1 | 2007 | 211 | 0.270 |
Why?
|
Predictive Value of Tests | 5 | 2017 | 15266 | 0.270 |
Why?
|
Macrolides | 2 | 2019 | 205 | 0.270 |
Why?
|
beta-Lactams | 2 | 2019 | 155 | 0.260 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2007 | 242 | 0.260 |
Why?
|
Rifampin | 2 | 2018 | 339 | 0.260 |
Why?
|
Laboratories | 2 | 2020 | 458 | 0.260 |
Why?
|
Histocytochemistry | 2 | 2018 | 698 | 0.260 |
Why?
|
Drug Therapy, Combination | 3 | 2020 | 6312 | 0.250 |
Why?
|
Anthrax | 1 | 2006 | 87 | 0.250 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2009 | 445 | 0.250 |
Why?
|
Fluoroquinolones | 2 | 2019 | 307 | 0.250 |
Why?
|
Bartonella henselae | 1 | 2004 | 15 | 0.250 |
Why?
|
Sputum | 1 | 2007 | 506 | 0.240 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3359 | 0.240 |
Why?
|
Haiti | 2 | 2017 | 550 | 0.240 |
Why?
|
Endothelial Cells | 3 | 2008 | 3548 | 0.240 |
Why?
|
Cell Line | 6 | 2019 | 15601 | 0.230 |
Why?
|
Virus Cultivation | 1 | 2024 | 88 | 0.230 |
Why?
|
Lymph Nodes | 1 | 2015 | 3466 | 0.230 |
Why?
|
Streptococcus | 1 | 2024 | 198 | 0.220 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 9002 | 0.210 |
Why?
|
Nucleic Acid Amplification Techniques | 2 | 2024 | 330 | 0.210 |
Why?
|
Drug Combinations | 2 | 2019 | 2048 | 0.210 |
Why?
|
Microbial Viability | 1 | 2024 | 238 | 0.210 |
Why?
|
Azithromycin | 2 | 2018 | 199 | 0.200 |
Why?
|
Animals | 17 | 2024 | 168467 | 0.200 |
Why?
|
Cell Division | 3 | 2023 | 4465 | 0.200 |
Why?
|
Automation | 2 | 2017 | 586 | 0.200 |
Why?
|
Cellulitis | 1 | 2024 | 209 | 0.200 |
Why?
|
HIV Seropositivity | 1 | 2007 | 960 | 0.200 |
Why?
|
Influenza B virus | 1 | 2021 | 52 | 0.190 |
Why?
|
Gene Transfer, Horizontal | 1 | 2022 | 145 | 0.190 |
Why?
|
Sterilization | 2 | 2020 | 133 | 0.180 |
Why?
|
Time | 2 | 2021 | 546 | 0.180 |
Why?
|
Travel | 2 | 2017 | 796 | 0.180 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2021 | 10766 | 0.180 |
Why?
|
Fishes | 1 | 2024 | 603 | 0.180 |
Why?
|
Diagnostic Tests, Routine | 3 | 2021 | 787 | 0.180 |
Why?
|
Microwaves | 2 | 2020 | 185 | 0.180 |
Why?
|
Ribosome Subunits | 1 | 2020 | 4 | 0.180 |
Why?
|
Equipment Reuse | 1 | 2020 | 45 | 0.180 |
Why?
|
Empathy | 2 | 2021 | 473 | 0.170 |
Why?
|
DNA | 1 | 2014 | 7213 | 0.170 |
Why?
|
Serologic Tests | 1 | 2022 | 381 | 0.170 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2016 | 755 | 0.170 |
Why?
|
Mice, Inbred BALB C | 2 | 2019 | 6214 | 0.170 |
Why?
|
Lincosamides | 1 | 2019 | 4 | 0.170 |
Why?
|
Diarrhea | 2 | 2017 | 1318 | 0.170 |
Why?
|
Pandemics | 6 | 2022 | 8656 | 0.170 |
Why?
|
Ribosomes | 1 | 2023 | 501 | 0.170 |
Why?
|
Disinfection | 2 | 2020 | 211 | 0.170 |
Why?
|
Filtration | 1 | 2020 | 228 | 0.170 |
Why?
|
Loneliness | 1 | 2021 | 203 | 0.160 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2021 | 150 | 0.160 |
Why?
|
Mononuclear Phagocyte System | 1 | 2018 | 54 | 0.160 |
Why?
|
Fosfomycin | 2 | 2016 | 24 | 0.160 |
Why?
|
Amines | 1 | 2020 | 281 | 0.160 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2023 | 1039 | 0.160 |
Why?
|
Plasmids | 2 | 2022 | 2269 | 0.160 |
Why?
|
X Chromosome | 2 | 2020 | 816 | 0.160 |
Why?
|
Escherichia coli Infections | 1 | 2023 | 518 | 0.160 |
Why?
|
Apoptosis | 3 | 2006 | 9489 | 0.160 |
Why?
|
Cryopreservation | 1 | 2024 | 728 | 0.160 |
Why?
|
Viral Load | 3 | 2022 | 3332 | 0.160 |
Why?
|
Molecular Structure | 2 | 2021 | 1880 | 0.160 |
Why?
|
Printing | 1 | 2018 | 46 | 0.160 |
Why?
|
Community Networks | 1 | 2020 | 201 | 0.160 |
Why?
|
Urinary Tract Infections | 2 | 2022 | 802 | 0.150 |
Why?
|
Mammals | 1 | 2024 | 1132 | 0.150 |
Why?
|
Methicillin | 1 | 2018 | 62 | 0.150 |
Why?
|
Antigens, Bacterial | 1 | 2004 | 1154 | 0.150 |
Why?
|
Glycopeptides | 1 | 2019 | 220 | 0.150 |
Why?
|
Aztreonam | 1 | 2017 | 10 | 0.150 |
Why?
|
Reproducibility of Results | 4 | 2020 | 20099 | 0.150 |
Why?
|
Mice | 11 | 2023 | 81533 | 0.150 |
Why?
|
Influenza A virus | 1 | 2021 | 458 | 0.150 |
Why?
|
Bacterial Load | 1 | 2018 | 152 | 0.150 |
Why?
|
rab GTP-Binding Proteins | 1 | 2019 | 250 | 0.150 |
Why?
|
Coccidioidomycosis | 1 | 2017 | 37 | 0.140 |
Why?
|
Methicillin Resistance | 1 | 2018 | 198 | 0.140 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2020 | 1693 | 0.140 |
Why?
|
R Factors | 1 | 2017 | 35 | 0.140 |
Why?
|
Drug Repositioning | 1 | 2019 | 233 | 0.140 |
Why?
|
Spectrum Analysis | 1 | 2019 | 453 | 0.140 |
Why?
|
Luminescent Measurements | 1 | 2018 | 342 | 0.140 |
Why?
|
Saliva | 1 | 2021 | 828 | 0.140 |
Why?
|
Microbial Interactions | 1 | 2017 | 74 | 0.140 |
Why?
|
Whole Body Imaging | 1 | 2018 | 283 | 0.140 |
Why?
|
RNA, Viral | 2 | 2021 | 2846 | 0.130 |
Why?
|
Skin Diseases, Parasitic | 1 | 2016 | 13 | 0.130 |
Why?
|
Hospitals, Teaching | 2 | 2014 | 1156 | 0.130 |
Why?
|
Antifungal Agents | 1 | 2021 | 753 | 0.130 |
Why?
|
Blood Transfusion | 1 | 2023 | 1301 | 0.130 |
Why?
|
Amebiasis | 1 | 2016 | 33 | 0.130 |
Why?
|
Gene Expression | 2 | 2019 | 7581 | 0.130 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2020 | 386 | 0.130 |
Why?
|
Cryoelectron Microscopy | 1 | 2020 | 650 | 0.130 |
Why?
|
Tetracyclines | 1 | 2015 | 64 | 0.130 |
Why?
|
Benzimidazoles | 1 | 2020 | 858 | 0.120 |
Why?
|
Dosage Compensation, Genetic | 1 | 2016 | 207 | 0.120 |
Why?
|
Cystitis | 1 | 2015 | 95 | 0.120 |
Why?
|
Triazoles | 1 | 2020 | 903 | 0.120 |
Why?
|
Doxycycline | 1 | 2017 | 344 | 0.120 |
Why?
|
Benchmarking | 1 | 2021 | 1045 | 0.120 |
Why?
|
Bacteriuria | 1 | 2015 | 102 | 0.120 |
Why?
|
Vancomycin | 1 | 2018 | 503 | 0.120 |
Why?
|
Structure-Activity Relationship | 2 | 2021 | 3076 | 0.120 |
Why?
|
Spleen | 3 | 2016 | 2295 | 0.120 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 560 | 0.120 |
Why?
|
Organic Chemicals | 1 | 2015 | 210 | 0.120 |
Why?
|
Immunoassay | 1 | 2018 | 745 | 0.120 |
Why?
|
Fatal Outcome | 2 | 2016 | 1835 | 0.120 |
Why?
|
Enterococcus | 1 | 2015 | 159 | 0.120 |
Why?
|
Neovascularization, Pathologic | 1 | 2004 | 2644 | 0.120 |
Why?
|
Quinazolines | 1 | 2020 | 1371 | 0.110 |
Why?
|
Luminescence | 1 | 2014 | 108 | 0.110 |
Why?
|
Thiazoles | 1 | 2021 | 1517 | 0.110 |
Why?
|
Pathology, Clinical | 1 | 1997 | 376 | 0.110 |
Why?
|
Th1 Cells | 1 | 2018 | 1036 | 0.110 |
Why?
|
X Chromosome Inactivation | 4 | 2020 | 227 | 0.110 |
Why?
|
Biopsy | 2 | 2016 | 6766 | 0.110 |
Why?
|
Endothelium, Vascular | 2 | 2004 | 4431 | 0.110 |
Why?
|
Indicators and Reagents | 1 | 2014 | 462 | 0.110 |
Why?
|
Imidazoles | 1 | 2019 | 1180 | 0.110 |
Why?
|
Macrophages, Alveolar | 1 | 2015 | 412 | 0.110 |
Why?
|
DNA Transposable Elements | 1 | 2017 | 755 | 0.110 |
Why?
|
Opportunistic Infections | 1 | 2016 | 376 | 0.100 |
Why?
|
Computer Systems | 1 | 2014 | 470 | 0.100 |
Why?
|
Immunologic Tests | 2 | 2024 | 104 | 0.100 |
Why?
|
Cell Membrane Permeability | 1 | 2014 | 575 | 0.100 |
Why?
|
Equipment Design | 1 | 2020 | 3511 | 0.100 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2020 | 954 | 0.100 |
Why?
|
Male | 17 | 2021 | 360842 | 0.100 |
Why?
|
Social Support | 1 | 2021 | 2171 | 0.100 |
Why?
|
Urinalysis | 1 | 2014 | 368 | 0.100 |
Why?
|
Fluorescence | 1 | 2014 | 756 | 0.100 |
Why?
|
Algorithms | 3 | 2020 | 14032 | 0.100 |
Why?
|
Feces | 1 | 2018 | 1497 | 0.100 |
Why?
|
Embryonic Development | 1 | 2016 | 721 | 0.090 |
Why?
|
Microscopy, Confocal | 1 | 2017 | 1971 | 0.090 |
Why?
|
Pyrazoles | 1 | 2021 | 2009 | 0.090 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2016 | 575 | 0.090 |
Why?
|
Trench Fever | 1 | 2010 | 2 | 0.090 |
Why?
|
Osteomyelitis | 1 | 2014 | 407 | 0.090 |
Why?
|
Genes, Neoplasm | 1 | 2012 | 370 | 0.090 |
Why?
|
Cat-Scratch Disease | 1 | 2010 | 23 | 0.090 |
Why?
|
Female | 17 | 2021 | 392686 | 0.090 |
Why?
|
Hospitals | 2 | 2020 | 3882 | 0.090 |
Why?
|
Gene Expression Profiling | 2 | 2018 | 9420 | 0.090 |
Why?
|
Quality Assurance, Health Care | 1 | 2020 | 2169 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2020 | 2986 | 0.080 |
Why?
|
Urine | 1 | 2011 | 362 | 0.080 |
Why?
|
Artificial Intelligence | 2 | 2022 | 2578 | 0.080 |
Why?
|
Penicillin-Binding Proteins | 1 | 2010 | 148 | 0.080 |
Why?
|
Middle Aged | 8 | 2021 | 220920 | 0.080 |
Why?
|
Sepsis | 1 | 2023 | 2585 | 0.080 |
Why?
|
Urethra | 1 | 2011 | 405 | 0.080 |
Why?
|
Cats | 1 | 2010 | 975 | 0.080 |
Why?
|
JC Virus | 1 | 2009 | 87 | 0.080 |
Why?
|
Genes, Tumor Suppressor | 1 | 2013 | 1062 | 0.080 |
Why?
|
Neoplasms | 2 | 2014 | 22173 | 0.080 |
Why?
|
Mycobacterium Infections | 1 | 2009 | 122 | 0.080 |
Why?
|
Radiography, Thoracic | 1 | 2014 | 1302 | 0.070 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2009 | 133 | 0.070 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2010 | 353 | 0.070 |
Why?
|
Pyridines | 1 | 2019 | 2875 | 0.070 |
Why?
|
Bronchoalveolar Lavage | 1 | 2007 | 129 | 0.070 |
Why?
|
Gastrointestinal Tract | 2 | 2020 | 833 | 0.070 |
Why?
|
Cervix Uteri | 1 | 2011 | 570 | 0.070 |
Why?
|
Hospitals, Urban | 1 | 2009 | 500 | 0.070 |
Why?
|
Myeloproliferative Disorders | 1 | 2013 | 613 | 0.070 |
Why?
|
Membrane Fusion | 1 | 2008 | 266 | 0.070 |
Why?
|
Atovaquone | 1 | 2006 | 56 | 0.070 |
Why?
|
Nitrofurantoin | 2 | 2016 | 18 | 0.070 |
Why?
|
Adult | 8 | 2021 | 221203 | 0.060 |
Why?
|
Babesiosis | 1 | 2006 | 92 | 0.060 |
Why?
|
Mice, SCID | 1 | 2010 | 2626 | 0.060 |
Why?
|
Genotype | 1 | 2019 | 12990 | 0.060 |
Why?
|
Referral and Consultation | 1 | 1997 | 3600 | 0.060 |
Why?
|
Splenectomy | 1 | 2006 | 391 | 0.060 |
Why?
|
Lymphoid Tissue | 1 | 2006 | 445 | 0.060 |
Why?
|
Cells, Cultured | 3 | 2008 | 18965 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8002 | 0.060 |
Why?
|
Ciprofloxacin | 2 | 2016 | 312 | 0.060 |
Why?
|
United States | 3 | 2022 | 72335 | 0.060 |
Why?
|
Young Adult | 4 | 2021 | 59255 | 0.060 |
Why?
|
Time Factors | 3 | 2018 | 39970 | 0.060 |
Why?
|
Cytokines | 1 | 2018 | 7396 | 0.060 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2004 | 817 | 0.060 |
Why?
|
Mice, Inbred Strains | 1 | 2006 | 1762 | 0.050 |
Why?
|
Bacillus anthracis | 1 | 2004 | 122 | 0.050 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 698 | 0.050 |
Why?
|
Aged | 7 | 2021 | 169310 | 0.050 |
Why?
|
Umbilical Veins | 1 | 2004 | 426 | 0.050 |
Why?
|
Lung | 2 | 2016 | 10002 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2020 | 58986 | 0.050 |
Why?
|
Myelodysplastic Syndromes | 1 | 2013 | 1394 | 0.050 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2002 | 68 | 0.050 |
Why?
|
Liver | 2 | 2010 | 7529 | 0.050 |
Why?
|
Virulence | 1 | 2006 | 1303 | 0.050 |
Why?
|
Endoplasmic Reticulum | 1 | 2008 | 1134 | 0.050 |
Why?
|
Ceftriaxone | 1 | 2023 | 175 | 0.050 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2006 | 242 | 0.050 |
Why?
|
Clinical Competence | 1 | 1997 | 4793 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2012 | 2639 | 0.050 |
Why?
|
Prednisone | 1 | 2006 | 1563 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2023 | 80646 | 0.050 |
Why?
|
HIV Infections | 3 | 2017 | 17352 | 0.050 |
Why?
|
Culture Media, Conditioned | 1 | 2002 | 522 | 0.040 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2012 | 1860 | 0.040 |
Why?
|
Antimalarials | 1 | 2006 | 907 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12975 | 0.040 |
Why?
|
Cell Survival | 2 | 2010 | 5791 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2004 | 1246 | 0.040 |
Why?
|
Social Isolation | 1 | 2021 | 364 | 0.040 |
Why?
|
Mice, Inbred A | 1 | 1998 | 246 | 0.040 |
Why?
|
Hyphae | 1 | 2017 | 52 | 0.040 |
Why?
|
RNA, Transfer | 1 | 2020 | 292 | 0.040 |
Why?
|
Spores, Fungal | 1 | 2017 | 90 | 0.040 |
Why?
|
Intracellular Membranes | 1 | 1998 | 389 | 0.040 |
Why?
|
Internship and Residency | 1 | 1997 | 5882 | 0.040 |
Why?
|
Transformation, Bacterial | 1 | 2017 | 76 | 0.040 |
Why?
|
Dogs | 1 | 2002 | 3839 | 0.030 |
Why?
|
Mitosis | 1 | 2002 | 1188 | 0.030 |
Why?
|
Amyloid beta-Peptides | 1 | 2010 | 3839 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2006 | 1809 | 0.030 |
Why?
|
Acanthamoeba castellanii | 1 | 2016 | 9 | 0.030 |
Why?
|
Ampicillin | 1 | 2016 | 136 | 0.030 |
Why?
|
Hemolysis | 1 | 1998 | 415 | 0.030 |
Why?
|
Judgment | 1 | 1997 | 273 | 0.030 |
Why?
|
Kidney | 1 | 2010 | 7047 | 0.030 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2016 | 178 | 0.030 |
Why?
|
Tumor Burden | 1 | 2020 | 1893 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2004 | 3492 | 0.030 |
Why?
|
Clone Cells | 1 | 2017 | 1659 | 0.030 |
Why?
|
Specialization | 1 | 1997 | 778 | 0.030 |
Why?
|
Genes, Lethal | 1 | 2013 | 223 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2017 | 2180 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2020 | 1403 | 0.030 |
Why?
|
Splenomegaly | 1 | 2013 | 189 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2012 | 11530 | 0.030 |
Why?
|
Fear | 1 | 2021 | 1477 | 0.030 |
Why?
|
Skin | 1 | 2006 | 4484 | 0.030 |
Why?
|
Mentors | 1 | 1997 | 661 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2016 | 1494 | 0.020 |
Why?
|
Protein Conformation | 1 | 2020 | 3968 | 0.020 |
Why?
|
Genome, Bacterial | 1 | 2017 | 783 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20571 | 0.020 |
Why?
|
Primary Myelofibrosis | 1 | 2013 | 209 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2021 | 2629 | 0.020 |
Why?
|
Latex Fixation Tests | 1 | 2010 | 29 | 0.020 |
Why?
|
Chromosomes, Human, X | 1 | 2012 | 321 | 0.020 |
Why?
|
Xanthenes | 1 | 2010 | 72 | 0.020 |
Why?
|
Cathelicidins | 1 | 2010 | 80 | 0.020 |
Why?
|
Models, Molecular | 1 | 2020 | 5439 | 0.020 |
Why?
|
Artifacts | 1 | 2018 | 1911 | 0.020 |
Why?
|
Urinary Bladder | 1 | 2015 | 1152 | 0.020 |
Why?
|
Contact Lenses, Hydrophilic | 1 | 1989 | 54 | 0.020 |
Why?
|
RNA, Untranslated | 1 | 2012 | 459 | 0.020 |
Why?
|
Alzheimer Disease | 1 | 2010 | 8601 | 0.020 |
Why?
|
Oxazines | 1 | 2010 | 350 | 0.020 |
Why?
|
Cross Infection | 1 | 2017 | 1422 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2021 | 5293 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2012 | 774 | 0.020 |
Why?
|
Candida albicans | 1 | 2010 | 372 | 0.020 |
Why?
|
Erythrocyte Inclusions | 1 | 2006 | 4 | 0.020 |
Why?
|
Mental Health | 1 | 2021 | 3250 | 0.020 |
Why?
|
Anxiety | 1 | 2021 | 4573 | 0.020 |
Why?
|
Cerebrospinal Fluid | 1 | 2009 | 544 | 0.020 |
Why?
|
Education, Medical | 1 | 1997 | 1725 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2016 | 3612 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54426 | 0.020 |
Why?
|
Antibodies, Protozoan | 1 | 2006 | 252 | 0.020 |
Why?
|
Boston | 1 | 2017 | 9326 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3778 | 0.010 |
Why?
|
Environment | 1 | 2010 | 1123 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2021 | 4575 | 0.010 |
Why?
|
Decision Making | 1 | 1997 | 3929 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2006 | 957 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10090 | 0.010 |
Why?
|
Platelet Count | 1 | 2006 | 781 | 0.010 |
Why?
|
Myocardium | 1 | 2016 | 4725 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15843 | 0.010 |
Why?
|
Up-Regulation | 1 | 2012 | 4124 | 0.010 |
Why?
|
Ligands | 1 | 2010 | 3272 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 2009 | 2571 | 0.010 |
Why?
|
Bone Marrow | 1 | 2013 | 2911 | 0.010 |
Why?
|
Genetic Variation | 1 | 2017 | 6567 | 0.010 |
Why?
|
Depression | 1 | 2021 | 8124 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 2006 | 1526 | 0.010 |
Why?
|
Oxygen | 1 | 2012 | 4227 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2013 | 3397 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2010 | 6534 | 0.010 |
Why?
|
Genome, Human | 1 | 2012 | 4425 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2010 | 3066 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2012 | 10448 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2006 | 4544 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 88324 | 0.010 |
Why?
|
Chronic Disease | 1 | 2006 | 9319 | 0.010 |
Why?
|
Inflammation | 1 | 2010 | 10773 | 0.010 |
Why?
|
Brain | 1 | 2010 | 27120 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 36429 | 0.000 |
Why?
|